Schedule 13G ownership disclosure

TRILLIUM THERAPEUTICS INC COM NEW

Security class unavailable · CUSIP: 89620X506

Event date: 2017-11-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,173,000
Percent of class
16.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-17-004518
Form type
SC 13G
Filer
Matrix Capital Management Company, LP
CIK
CIK 1410830
Filed
Dec 08, 2017
Reporting period
Nov 30, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub